Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.
@article{Tai2001CompoundHF, title={Compound heterozygous familial hypercholesterolemia and familial defective apolipoprotein B-100 produce exaggerated hypercholesterolemia.}, author={E. Tai and E. Koay and E. Chan and T. J. Seng and L. Loh and S. Sethi and C. E. Tan}, journal={Clinical chemistry}, year={2001}, volume={47 3}, pages={ 438-43 } }
BACKGROUND
Familial hypercholesterolemia (FH) and familial defective apolipoprotein B-100 (FDB) represent ligand-receptor disorders that are complementary. Individuals with both FH and FDB are unusual. We report a family with both disorders and the impact of the mutations on the phenotypes of the family members.
METHODS
We used single strand conformation polymorphism (SSCP) and denaturing gradient gel electrophoresis (DGGE) for genetic analysis of all 18 exons and the promoter region of the… Expand
17 Citations
A double heterozygote for familial hypercholesterolaemia and familial defective apolipoprotein B-100
- Biology, Medicine
- Annals of clinical biochemistry
- 2010
- 21
Molecular Description of Familial Defective APOB-100 in Malaysia
- Biology, Medicine
- Biochemical Genetics
- 2013
- 5
Familial hypercholesterolemia/autosomal dominant hypercholesterolemia: Molecular defects, the LDL-C continuum, and gradients of phenotypic severity.
- Medicine
- Journal of clinical lipidology
- 2016
- 14
Double-heterozygous autosomal dominant hypercholesterolemia: Clinical characterization of an underreported disease.
- Medicine
- Journal of clinical lipidology
- 2016
- 20
Familial defective apolipoprotein B-100: a tale of twin mutations.
- Medicine
- Journal of clinical lipidology
- 2016
- 4
The Digenic Causality in Familial Hypercholesterolemia: Revising the Genotype–Phenotype Correlations of the Disease
- Medicine
- Frontiers in Genetics
- 2020
- Highly Influenced
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia.
- Medicine
- Atherosclerosis
- 2006
- 100
New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia
- Biology, Medicine
- Scientific Reports
- 2018
- 11
- PDF
References
SHOWING 1-10 OF 29 REFERENCES
Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
- Medicine
- Archives of internal medicine
- 1993
- 82
Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.
- Medicine
- Atherosclerosis
- 1993
- 198
Clinically applicable mutation screening in familial hypercholesterolemia
- Biology, Medicine
- Human mutation
- 1996
- 48
Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100.
- Biology, Medicine
- Proceedings of the National Academy of Sciences of the United States of America
- 1989
- 572
- PDF
Phenotypic expression in double heterozygotes for familial hypercholesterolemia and familial defective apolipoprotein B‐100
- Biology, Medicine
- Human mutation
- 1996
- 26
Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations.
- Biology, Medicine
- Molecular and cellular probes
- 1998
- 14
Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics.
- Medicine
- The American journal of cardiology
- 1993
- 442
A cholesterol-lowering gene maps to chromosome 13q.
- Biology, Medicine
- American journal of human genetics
- 2000
- 57
Denaturing gradient-gel electrophoresis screening of familial defective apolipoprotein B-100 in a mixed Asian cohort: two cases of arginine3500-->tryptophan mutation associated with a unique haplotype.
- Medicine, Biology
- Clinical chemistry
- 1997
- 32
- PDF
Common mutations in the low-density-lipoprotein-receptor gene causing familial hypercholesterolemia in the Japanese population.
- Biology, Medicine
- Arteriosclerosis, thrombosis, and vascular biology
- 1995
- 28